PE Ratio
N/A
Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| PE Ratio | - | – | – | – | – | – | – | – | |
| Price | $76.84 | -0.4% | -5.3% | -1.6% | +20.9% | +101.9% | +133.3% | +151.4% | |
| TTM Revenue | $67.67M | -36.0% | – | -36.0% | – | -21.1% | +580.0% | +17.1% | |
| TTM EPS | -$7.22 | -5.5% | – | -5.5% | – | -41.0% | -26.9% | -230.4% | |
| -61.58 | +0.4% | +3.0% | -380.3% | -420.1% | -399.0% | -548.9% | -146.2% | ||
| 157.86 | -0.4% | -3.0% | +57.6% | +77.9% | +197.4% | -50.3% | +315.2% | ||
| $10.78B | -0.4% | -3.0% | -2.5% | +31.3% | +137.1% | +222.6% | +417.6% | ||
| -15.51 | +0.5% | +2.9% | +11.8% | -13.7% | -83.3% | -118.8% | +7.3% | ||
| Market Cap | $11B | -0.4% | -3.0% | +0.8% | +36.8% | +134.7% | +238.0% | +386.1% |
Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1M | N/A | N/A | N/A |
| 3M | N/A | N/A | N/A |
| 6M | N/A | N/A | N/A |
| 1Y | N/A | N/A | N/A |
| 3Y | N/A | N/A | N/A |
| 5Y | N/A | N/A | N/A |
| All | 850.00 | N/A |
Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1M | N/A | N/A | N/A |
| 3M | N/A | N/A | N/A |
| 6M | N/A | N/A | N/A |
| 1Y | N/A | N/A | N/A |
| 3Y | N/A | N/A | N/A |
| 5Y | N/A | N/A | N/A |
| All | 5.93 | N/A |
History
| Date | Value | Change |
|---|---|---|
| 36.82 | +431.3% |
| Date | Value | Change |
|---|---|---|
| 6.93 | - |
Formula
Data Sources & References
- CYTK Official Website www.cytokinetics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1061983/000119312526076495/0001193125-26-076495-index.htm
- CYTK Profile on Yahoo Finance finance.yahoo.com/quote/CYTK
- CYTK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cytk
